期刊文献+

Pharmacokinetic behavior of 16-dehydropregnenolone after intramuscular administration in rats

Pharmacokinetic behavior of 16-dehydropregnenolone after intramuscular administration in rats
下载PDF
导出
摘要 The pharmacokinetics of 16-dehydropregnenolone (16-DHP), a sterols compound isolated from Solanum lyratum Thunb., was investigated in rats following a single intramuscular administration (40 mg/kg). The concentration of 16-DHP in rat plasma was determined by a high performance liquid chromatography (HPLC) method with UV detection. Levonorgestrel was used as the internal standard (IS). The pharmacokinetic parameters of 16-DHP were derived by non-compartmental method. After a single intramuscular administration, the maximum plasma concentration (Cmax) was (289±25)ng/mL, time to reach Cmax(tmax) was (0.38±0.14) h, the elimination half-life (t1/z) was (2.5±1.1)h, the area under the plasma concentration-time curve from time zero to the time of the last measurable concentration (AUC(0-t)) was (544± 73)ng· h/mL. The results indicated that 16-DHP was absorbed quickly and eliminated rapidly in rats after the intramuscular injection. The pharmacokinetics of 16-dehydropregnenolone (16-DHP), a sterols compound isolated from Solanum lyratum Thunb., was investigated in rats following a single intramuscular administration (40 mg/kg). The concentration of 16-DHP in rat plasma was determined by a high performance liquid chromatography (HPLC) method with UV detection. Levonorgestrel was used as the internal standard (IS). The pharmacokinetic parameters of 16-DHP were derived by non-compartmental method. After a single intramuscular administration, the maximum plasma concentration (Cmax) was (289±25)ng/mL, time to reach Cmax(tmax) was (0.38±0.14) h, the elimination half-life (t1/z) was (2.5±1.1)h, the area under the plasma concentration-time curve from time zero to the time of the last measurable concentration (AUC(0-t)) was (544± 73)ng· h/mL. The results indicated that 16-DHP was absorbed quickly and eliminated rapidly in rats after the intramuscular injection.
出处 《Journal of Pharmaceutical Analysis》 SCIE CAS 2011年第2期135-138,共4页 药物分析学报(英文版)
基金 supported by the Science and Technolog Department of Liaoning Province(No.2007226011) Shenyang Office of Science and Technology(No.10711649-00)
关键词 16-dehydropregnenolone intramuscular administration PHARMACOKINETICS high performance liquid chroma- tography 16-dehydropregnenolone intramuscular administration pharmacokinetics high performance liquid chroma- tography
  • 相关文献

参考文献7

  • 1Li-Xin Sun,Wen-wei Fu,Jing Ren,Liang Xu,Kai-Shun Bi,Min-Wei Wang.Cytotoxic constituents fromSolanum lyratum[J]. Archives of Pharmacal Research . 2006 (2)
  • 2Kurosaki Y,Tagawa M,Omoto Aet al.Evaluation of intramuscular lat-eral distribution profile of topically administered acetaminophen in rats. International Journal of Pharmaceutics . 2007
  • 3Wu WY,Gao ZG,Li YGet al.Chemical constituents and biological ac-tivities of Solanumlyratum Thunb.and Solanumdulcamara Linn. World Notes Plant Med . 2001
  • 4Ling YZ,Li JZ,Kato Z.Synthesis andin vitroactivity of some epimeric20α-hydroxy,20-oxime and aziridine pregnene derivatives as inhibitors of human17α-hydroxylase/C17,20-lyase and5α-redutase. Bioorganic and Medicinal Chemistry . 1998
  • 5RamP,Chander GR.Medicaments for hyperlipidemic and hyperglycemic conditions. EP19990302556 . 2008
  • 6Suryawanshi S,SinghSK,Gupta RC.Asensitive andselective HPLC/ESI-MS/MS assayfor thesimultaneous quantification of16-dehydropregnenolo-ne andits major metabolites inrabbit plasma. Journal of Chromatography B . 2006
  • 7Singh SK,Mehrotra N,Sabarinath Set al.HPLC-UV method develop-ment and validationfor16-dehydropregnenolone,a novel oral hypolipidae-mic agent,in rat biological matrices for application to pharmacokinetic studies. J PharmBio Anal . 2003

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部